[Letter: Thrombolitic drugs].
D004361:Drug Tolerance; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D013300:Streptokinase / Q000009:adverse effects; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects
D005343:Fibrinolytic Agents; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
A propos des médications thrombolytiques